TickerFactsScreenerDevelopers

HALOZYME THERAPEUTICS, INC. (HALO) — Revenue

Annual figures by fiscal year, from SEC filings.

2017: $316.61M2018: $151.86M2019: $195.99M2020: $267.59M2021: $443.31M2022: $660.12M2023: $829.25M2024: $1.02B2025: $1.40B$1.40B
2017Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$1.40B+37.6%
2024$1.02B+22.4%
2023$829.25M+25.6%
2022$660.12M+48.9%
2021$443.31M+65.7%
2020$267.59M+36.5%
2019$195.99M+29.1%
2018$151.86M-52.0%
2017$316.61M—